insurance changes to glp-1 drugs Patients Face New Barriers for Why payers are hesitant to

Description

Diabetologia (2010) 53(1):1539

Diabet Med 2008;25:11291131

Nutritional Deficiencies with weekly GLP-1 Receptor Agonists (Ozempic & Mounjaro): What patients Need to Know Introduction Some medicines used for treating diabetes and helping with weight loss are called GLP-1 GLP-1 Receptor Agonists and Nutritional Deficiencies: What You Need to Know Many adults with type 2 diabetes or obesity are now using GLP-1 receptor agonists (GLP-1 RAs) a class of medications that lower blood sugar and help with weight loss

Food and Drug Administration (FDA) specifically for weight management : Saxenda (liraglutide) Novo Nordisk Wegovy (semaglutide) Novo Nordisk Zepbound (tirzepatide) Eli Lilly Although Saxenda received approval in 2014, it was not until Wegovys launch in 2021 that the weight loss potential of GLP-1s gained widespread public attention